World Heart Federation Cholesterol Roadmap: The Portuguese case

• DOI: 10.1016/j.repc.2024.04.009
• Publication Date: 2024-07-06T02:30:54Z
• Authors: Ana Abreu; Hélder Dores; Lino Gonçalves; Fátima Franco; Conceição Silveira; Gonçalo Proença; Ana Teresa Timóteo; Nuno Cardim; Mónica Pedro; Manuela Fiuza; Daniel Ferreira; Luísa Bento; Lino Patrício; Daniel Caldeira; Sérgio Bravo Bapt...; José Santos; Evangelista Rocha; Anabela Raimundo; Carlos Catarino; Manuel Carrageta; Ricardo Mexia; Francisco Araújo; Hélder Pereira; Raul Santos; Fausto J. Pinto
• Keywords: WHF roadmap; Doença aterosclerótica cardiovascular; Prevention; WHF Roadmap; Risco cardiovascular; Cardiovascular risk; Cholesterol; 0302 clinical medicine; Atherosclerotic cardiovascular disease; RC666-701; Diseases of the circulatory (Cardiovascular) system; Prevenção; Colesterol

Atherosclerotic cardiovascular disease (ASCVD) remains the major cause of premature death and disability; effective cardiovascular (CV) risk prevention is fundamental. The World Heart Federation (WHF) Cholesterol Roadmap provides a framework for national policy development and aims to achieve ASCVD prevention.At the invitation of the WHF, a group of experts from the Portuguese Society of Cardiology (SPC), addressed the cholesterol burden at the national level and discussed possible strategies to include in a Portuguese cholesterol roadmap. The literature review showed that the cholesterol burden in Portugal is high and especially uncontrolled in those with the highest CV risk. An infographic, scorecard, was built to include in the WHF collection, for a clear idea about CV risk and cholesterol burden in Portugal, which would also be useful for health policy advocacy.The expert discussion and preventive strategies proposal followed the five pillars of the WHF document: Awareness improvement; Population-based approaches for CV risk and cholesterol; Risk assessment /population screening; System-level approaches; Surveillance of cholesterol and ASCVD outcomes. These strategies were debated by all the expert participants, with the goal of creating a national cholesterol roadmap to be used for advocacy and as a guide for CV prevention.Several key recommendations were made: Include all stakeholders in a multidisciplinary national program; Create a structured activities plan to increase awareness in the population; Improve the quality of continuous CV health education; Increase the interaction between different health professionals and non-health professionals; Increment the referral of patients to cardiac rehabilitation; Screen cholesterol levels in the general population, especially high-risk groups; Promote patients' self-care, engaging with patients' associations; Use specific social networks to spread information widely; Create a national database of cholesterol levels with systematic registry of CV events; Redefine strategies based on the evaluation of results; Create and involve more patients' associations - invert the pyramid order. In conclusion: ASCVD and the cholesterol burden remain a strong global issue in Portugal, requiring the involvement of multiple stakeholders in prevention. The Portuguese cholesterol roadmap can provide some solutions to help mitigate the problem urgently. Population-based approaches to improve awareness and CV risk assessment and surveillance of cholesterol and ASCVD outcomes are key factors in this change. A call to action is clearly needed to fight hypercholesterolemia and ASCVD burden.